DashboardAll companies
Run this on your own research
Healthcare · Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Co., Ltd.

4502JPX¥6,389+¥41 (+0.65%)Market closed

Price Chart

Daily

Key facts

Market Cap
¥10.09T
P/E
−66.0x
P/B
1.35x
ROE
−2.1%

Takeda Pharmaceutical Co., Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic · FY 2026

Takeda Pharmaceutical Co., Ltd. is a leading global biopharmaceutical company headquartered in Japan. Its primary purpose is to discover, develop, and deliver innovative medicines that improve patients' lives, focusing on four main therapeutic areas: oncology, rare diseases, neuroscience, and gastroenterology. Takeda also invests in plasma-derived therapies and vaccines. Known for its strong research and development capabilities, Takeda drives advancements through both internal development efforts and strategic partnerships across the globe. As one of the largest pharmaceutical firms by revenue, Takeda plays a significant role in the healthcare industry, impacting patient care worldwide. The company's extensive global network enables it to serve patients in over 80 countries, underscoring its commitment to accessibility and impact in the pharmaceutical market.

CEO
Mr. Christophe Weber
Employees
47,455
Website
takeda.com

Company Statistics

Valuation

P/E
−66.0x
P/B
1.35x
P/S
2.23x
EV/EBITDA
12.1x
P/FCF
16.1x

Margins

Gross
65.1%
EBITDA
26.4%
Operating
10.3%
Pre-Tax
−3.2%
Net
−3.4%

Returns

ROA
−1.0%
ROE
−2.1%
ROIC
0.0%

Growth (CAGR)

Rev 3Yr
3.8%
Rev 5Yr
7.1%
Op Inc 3Yr
−5.8%
Net Inc 3Yr
—

Financial Health

Cash & Cash Equivalents
¥595.05B
Net Debt
¥7.49T
Debt/Equity
108.8%
Interest Cov
—

Profile

Revenue
¥4.51T
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Takeda Pharmaceutical Co., Ltd. (4502) Stock Forecast 2026 ¥6,389 — Price, Financials & Analyst Targets | AlphaLenz